Australia's EBR Systems rises on heart pacer implants in the U.S.
View all comments(0)
Shares of EBR Systems EBR.AX rises as much as 9.5% to A$1.215, set for their strongest intraday session since May 23
Medtech firm says heart pacer WiSE System has been successfully implanted in the first commercial patients in the U.S., following recent FDA approval
Adds, it remains on track for initiation of its limited market release and expected reimbursement add-on payments commencing October
Stock last up 5.4%, taking YTD gains to 14.2%
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

April 2026 CPI Preview: Will Hot Inflation Crush Nasdaq, S&P 500 & NVDA? Explosive Market Reaction Guide

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.